首页> 外文OA文献 >Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Fails

【2h】

Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Fails

机译：用于艾滋病毒1型感染患者的二线抗逆转录病毒方案的选择，其定位剂量组合的初始方案的血管血管，拉夫法林和奈韦拉滨的固定剂量组合失败

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
S. Sungkanuparph; W. Manosuth; S. Kiertiburanakul; B. Piyavong; N. Chumpathat; W. Chantratita;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Fails [J] . Somnuek Sungkanuparph1 Weerawat Manosuth2 Sasisopin Kiertiburanakul1 Bucha Piyavong1 Noppanath Chumpathat2 and Wasun Chantratita1 Clinical Infectious Diseases . 2007,第3期

机译：HIV 1型感染患者的二线抗逆转录病毒治疗方案的选择，这些患者的固定剂量联合用司他夫定，拉米夫定和奈韦拉平治疗失败
2. Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine. [J] . Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology . 2008,第4期

机译：HIV-1感染的患者中出现K65R突变的患病率和危险因素，这些患者在初始剂量的司他夫定，拉米夫定和奈韦拉平联合固定治疗方案失败后失败。
3. Effectiveness and Metabolic Complications After 96 Weeks of a Generic Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Among Antiretroviral-Naive Advanced HIV-Infected Patients in Thailand: A Prospective Study [J] . Weerawat Manosuthi, Somnuek Sungkanuparph, Somsit Tansuphaswadikul, Current therapeutic research, clinical and experimental. . 2008,第1期

机译：在泰国接受抗逆转录病毒治疗的晚期HIV感染患者中，stavudine，lamivudine和nevirapine常规固定剂量联合使用96周后的疗效和代谢并发症：一项前瞻性研究
4. The Two First-Line Recommended Antiretroviral Regimens for Naive HIV-Infected Patients: Efavirenz-Based Versus Lopinavir-Ritonavir-Based Haart [C] . R. Manfredi, L. Calza, F. Chiodo International AIDS Conference . 2004

机译：幼稚艾滋病毒感染患者的两种第一线推荐的抗逆转录病毒方案：efavirenz为基于Lopinavir-Ritonavir的HAART
5. Cost-Effectiveness of Antiretroviral Therapy Regimens for HIV-Positive Pregnant Women in Ghana: A Case for Option B-Plus. [D] . VanDeusen, Adam. 2013

机译：加纳艾滋病毒阳性孕妇的抗逆转录病毒疗法方案的成本效益：选项B-Plus的案例。
6. Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine lamivudine and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study [O] . Weerawat Manosuthi, Somnuek Sungkanuparph, Somsit Tansuphaswadikul, 2008

机译：一项在泰国接受抗逆转录病毒治疗的晚期HIV感染患者中司他夫定拉米夫定和奈韦拉平的固定剂量普通药物联合治疗96周后的疗效和代谢并发症：一项前瞻性研究
7. Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study [O] . Manosuthi Weerawat, Sungkanuparph Somnuek, Tansuphaswadikul Somsit, 2008

机译：在泰国接受抗逆转录病毒治疗的晚期HIV感染患者中，使用司他夫定，拉米夫定和奈韦拉平的固定剂量普通药物联合治疗96周后的疗效和代谢并发症：一项前瞻性研究

Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Fails

著录项

引文网络

相似文献

相关主题

期刊订阅